ImmuPharma PLC

IMM

Company Profile

  • Business description

    ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease.

  • Contact

    One Bartholomew Close
    LondonEC1A 7BL
    GBR

    T: +44 2072062650

    E: [email protected]

    https://www.immupharma.co.uk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    3

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,421.7021.900.26%
CAC 407,694.4467.600.89%
DAX 4023,352.69236.731.02%
Dow JONES (US)41,368.45254.480.62%
FTSE 1008,531.6127.72-0.32%
HKSE22,775.9284.040.37%
NASDAQ17,928.14189.981.07%
Nikkei 22536,928.63148.970.41%
NZX 50 Index12,560.7093.670.75%
S&P 5005,663.9432.660.58%
S&P/ASX 2008,191.7013.400.16%
SSE Composite Index3,352.009.330.28%

Market Movers